MashupMD (@mdmashup) 's Twitter Profile
MashupMD

@mdmashup

MashupMD is a medical platform that links specialists with the social media conversations going on in their fields. Follow for news in health care and medicine.

ID: 1182281590933803008

linkhttps://mashupmd.com/ calendar_today10-10-2019 13:08:01

1,1K Tweet

678 Followers

3,3K Following

CardiocareToday.com (@cardiocaretoday) 's Twitter Profile Photo

💡 A $2.6M NIH grant backs a precision gene-editing project targeting HCM, the most common inherited heart condition. cardiocaretoday.com/post/2-6-milli… #GeneTherapy #HCM #CardioTwitter #Genetics

💡 A $2.6M NIH grant backs a precision gene-editing project targeting HCM, the most common inherited heart condition.

cardiocaretoday.com/post/2-6-milli… 

#GeneTherapy #HCM #CardioTwitter #Genetics
Cancer Nursing Today (@cancer_nurses) 's Twitter Profile Photo

💬 Dostarlimab plus chemo is comparable to placebo plus chemo for time to first quality of life improvement or deterioration in patients with advanced or recurrent endometrial cancer, according to a recent study presented at #ASCO25. ➡️ Read more: buff.ly/etqfrfK

💬 Dostarlimab plus chemo is comparable to placebo plus chemo for time to first quality of life improvement or deterioration in patients with advanced or recurrent endometrial cancer, according to a recent study presented at #ASCO25.

➡️ Read more: buff.ly/etqfrfK
MashupMD (@mdmashup) 's Twitter Profile Photo

🫀New CardioNerds episodes this month cover how HFpEF impacts metabolic, hormonal, and inflammatory factors in women’s health, multimodal imaging with Dr. Monica Mukherjee, and more Learn more: mashupmd.com/expert-collect…

🫀New <a href="/CardioNerds/">CardioNerds</a> episodes this month cover how HFpEF impacts metabolic, hormonal, and inflammatory factors in women’s health, multimodal imaging with Dr. Monica Mukherjee, and more

Learn more: mashupmd.com/expert-collect…
GI Oncology Now (@gioncnow) 's Twitter Profile Photo

📺Watch our new interview with Scott Kopetz, where he explains how the BREAKWATER trial aligns with the FDA’s Project FrontRunner initiative by using early response rate data to support accelerated approval in BRAF V600E-mutated metastatic #colorectal cancer: gioncologynow.com/post/breakwate…

MashupMD (@mdmashup) 's Twitter Profile Photo

🥑This week, Joel "Heart Prevention" Kahn MD, FACC asks if ketogenic diets promote cancer and if plant-based diets prevent it. Also covered: diet quality and heart health, the President’s swollen ankles, homocysteine, AI and ECGs, and more. ➡️Continue reading: mashupmd.com/expert-collect…

🥑This week, <a href="/drjkahn/">Joel "Heart Prevention" Kahn MD, FACC</a> asks if ketogenic diets promote cancer and if plant-based diets prevent it. Also covered: diet quality and heart health, the President’s swollen ankles, homocysteine, AI and ECGs, and more.

➡️Continue reading: mashupmd.com/expert-collect…
GU Oncology Now (@guoncologynow) 's Twitter Profile Photo

⚙️ A new evaluation of several trials has shed light on the prognostic performance of the 15G score in patients with metastatic #ccRCC. 📉 Learn which treatments - including #sunitinib and #atezolizumab - were linked to worse PFS rates: guoncologynow.com/post/15-gene-p…

Blood Cancers Today (@blood_cancers) 's Twitter Profile Photo

ICYMI: In a retrospective review presented at #ASCO25, patients with newly diagnosed #myeloma were considered to be at high risk for venous thromboembolism if they had a SAVED score of 2 or higher or an IMPEDE score of 4 or higher. 📰 buff.ly/0Y95VIR

ICYMI: In a retrospective review presented at #ASCO25, patients with newly diagnosed #myeloma were considered to be at high risk for venous thromboembolism if they had a SAVED score of 2 or higher or an IMPEDE score of 4 or higher. 

📰 buff.ly/0Y95VIR
Cancer Nursing Today (@cancer_nurses) 's Twitter Profile Photo

🤔 Can a nursing model improve immune balance and response in patients with liver cancer undergoing SBRT Cyberknife treatment? ⚕️ A team of researchers from China addressed the question. ➡️ Read more: buff.ly/3F68CYe #livercancer #GIcancer #CancerNursingToday

🤔 Can a nursing model improve immune balance and response in patients with liver cancer undergoing SBRT Cyberknife treatment?

⚕️ A team of researchers from China addressed the question.

➡️ Read more: buff.ly/3F68CYe

#livercancer #GIcancer #CancerNursingToday
MashupMD (@mdmashup) 's Twitter Profile Photo

🚨 PSMA PET imaging and radioligand therapy are gaining ground in prostate cancer. GU Oncology Now spoke with experts on studies investigating the efficacy of these tools. 🔗 mashupmd.com/expert-collect…

🚨 PSMA PET imaging and radioligand therapy are gaining ground in prostate cancer. <a href="/GUOncologyNow/">GU Oncology Now</a> spoke with experts on studies investigating the efficacy of these tools.

🔗 mashupmd.com/expert-collect…
GI Oncology Now (@gioncnow) 's Twitter Profile Photo

🧬 The #KRAS gene is one of the most common oncogenic drivers in #GICancers Today, researchers have been expanding their efforts in targeting the gene and its mutations: buff.ly/zaXH1kB

MashupMD (@mdmashup) 's Twitter Profile Photo

🔬 Predictive genomics is transforming breast cancer care by guiding treatment choices. Dr. Sadie Dobrozsi highlights how pharmacogenomics goes further to personalize dosing and reduce trial and error. Learn more: mashupmd.com/expert-collect…

🔬 Predictive genomics is transforming breast cancer care by guiding treatment choices. Dr. Sadie Dobrozsi highlights how pharmacogenomics goes further to personalize dosing and reduce trial and error.

Learn more: mashupmd.com/expert-collect…
GU Oncology Now (@guoncologynow) 's Twitter Profile Photo

📺 In our recent video series, Drs. Vignesh Packiam, MD of Rutgers Cancer Institute and Nitin Yerram M.D. of HackensackUMC Department of Urology explore the latest advances in #NMIBC, including combination #immunotherapy with BCG: buff.ly/Q3kTagh 👉 In the final part of the series, they conclude with the

MashupMD (@mdmashup) 's Twitter Profile Photo

Target trial emulation is the new hotness in retrospective research. 🎧 In the latest Freely Filtered, Joel M. Topf, MD FACP and Ed Fu break down metformin use below eGFR 30, depletion of susceptibles, SGLT2i in dialysis, and more. Learn more: mashupmd.com/expert-collect…

Target trial emulation is the new hotness in retrospective research.

🎧 In the latest Freely Filtered, <a href="/kidney_boy/">Joel M. Topf, MD FACP</a> and Ed Fu break down metformin use below eGFR 30, depletion of susceptibles, SGLT2i in dialysis, and more. 

Learn more: mashupmd.com/expert-collect…
MashupMD (@mdmashup) 's Twitter Profile Photo

🧬Precision medicine is changing CRC care fast. @Marshalj23 highlights why frontline testing for RAS, BRAF, HER2, and MSI is now essential. BREAKWATER shows BRAF can guide treatment, not just predict poor outcomes. ➡️mashupmd.com/expert-collect…

🧬Precision medicine is changing CRC care fast. @Marshalj23 highlights why frontline testing for RAS, BRAF, HER2, and MSI is now essential. BREAKWATER shows BRAF can guide treatment, not just predict poor outcomes.

➡️mashupmd.com/expert-collect…
Blood Cancers Today (@blood_cancers) 's Twitter Profile Photo

In this Editor’s Special Episode of The HemOnc Pulse, Gurbakhash Kaur (Mount Sinai Health System) and Danai Dima (Fred Hutch Cancer Center) explore the most promising investigational and newly approved therapies for patients with relapsed or refractory multiple #myeloma. 🎧 Listen here! buff.ly/9xE7iLO

In this Editor’s Special Episode of The HemOnc Pulse, <a href="/GKaurMD/">Gurbakhash Kaur</a> (<a href="/MountSinaiNYC/">Mount Sinai Health System</a>) and <a href="/DimaDanai/">Danai Dima</a> (<a href="/fredhutch/">Fred Hutch Cancer Center</a>) explore the most promising investigational and newly approved therapies for patients with relapsed or refractory multiple #myeloma.

🎧 Listen here! buff.ly/9xE7iLO
Nephrology Times (@neph_times) 's Twitter Profile Photo

⚠️ ICYMI: Ajay Singh's latest column looks at sex differences in glomerular filtration rate. #nephrology #nephtwitter #kidneydisease #GFR buff.ly/BYueUek

⚠️ ICYMI: Ajay Singh's latest column looks at sex differences in glomerular filtration rate. #nephrology #nephtwitter #kidneydisease #GFR buff.ly/BYueUek
MashupMD (@mdmashup) 's Twitter Profile Photo

🧠This week from Joel "Heart Prevention" Kahn MD, FACC: Heart-healthy habits may cut dementia risk, glipizide raises heart risk, and 7,000 steps may be enough. Red date vinegar helps with glucose and cholesterol. Plant-based diets cut Crohn’s risk. 💡Learn more: mashupmd.com/expert-collect…

🧠This week from <a href="/drjkahn/">Joel "Heart Prevention" Kahn MD, FACC</a>: Heart-healthy habits may cut dementia risk, glipizide raises heart risk, and 7,000 steps may be enough. Red date vinegar helps with glucose and cholesterol. Plant-based diets cut Crohn’s risk. 

💡Learn more: mashupmd.com/expert-collect…
GI Oncology Now (@gioncnow) 's Twitter Profile Photo

⭐ In our new profile interview, Dr. Olatunji B. Alese of Winship Cancer Institute of Emory University discusses his career in GI oncology care, from his involvement in landmark clinical trials to his passion for advancing precision medicine: buff.ly/vpAuafF

Cancer Nursing Today (@cancer_nurses) 's Twitter Profile Photo

⭐ COMING SOON: We're announcing our 2025 CARE Award finalists and opening voting for our 2025 CARE Award winner tomorrow! ➡️ Stay tuned for the finalist announcement, voting ballot, and more here: buff.ly/QGhFO1o #CAREaward2025 #CancerNursesCARE

⭐ COMING SOON: We're announcing our 2025 CARE Award finalists and opening voting for our 2025 CARE Award winner tomorrow! 

➡️ Stay tuned for the finalist announcement, voting ballot, and more here: buff.ly/QGhFO1o 

#CAREaward2025 #CancerNursesCARE
MashupMD (@mdmashup) 's Twitter Profile Photo

🚨 Introducing JCF-Intersections! The inaugural article explores EP and HF through the AFFIRM trial. This is the first of several articles leading to the premier issue in September. ➡️Stay updated with Journal of Cardiac Failure: mashupmd.com/expert-collect…

🚨 Introducing JCF-Intersections! The inaugural article explores EP and HF through the AFFIRM trial. This is the first of several articles leading to the premier issue in September. 

➡️Stay updated with <a href="/JCardFail/">Journal of Cardiac Failure</a>: mashupmd.com/expert-collect…